Central nervous system: a modified immune surveillance circuit?
Immune surveillance in the central nervous system (CNS) was considered impossible because: (i) the brain parenchyma is separated from the blood circulation by the blood-brain barrier (BBB); (ii) the brain lacks lymphatic drainage and (iii) the brain displays low major histocompatibility complex class II (MHCII) expression. In this context, the BBB prevents entry of immune molecules and effector cells to the CNS. The absence of lymphatic vessels avoids CNS antigens from reaching the lymph nodes for lymphocyte presentation and activation. Finally, the low MHCII expression hinders effective antigen presentation and re-activation of T cells for a competent immune response. All these factors limit the effectiveness of the afferent and efferent arms necessary to carry out immune surveillance. Nevertheless, recent evidence supports that CNS is monitored by the immune system through a modified surveillance circuit; this work reviews these findings.
Grupo de Biología y Salud Integral, Instituto de Investigaciones biológicas, Universidad Veracruzana, Xalapa, Veracruz, Mexico.
Tania
T
Romo-González
Anahí
A
Chavarría
Jesús
J
Pérez-H
D000818:Animals; D017951:Antigen Presentation; D000941:Antigens / Q000032:analysis / Q000276:immunology; D001812:Blood-Brain Barrier / Q000276:immunology / Q000502:physiology; D002465:Cell Movement; D002490:Central Nervous System / Q000276:immunology*; D005802:Genes, MHC Class II / Q000235:genetics; D006801:Humans; D007157:Immunologic Surveillance / Q000276:immunology* / Q000502:physiology*; D008198:Lymph Nodes / Q000276:immunology / Q000502:physiology; D008208:Lymphatic System / Q000502:physiology; D009103:Multiple Sclerosis / Q000276:immunology; D015213:Neuroimmunomodulation / Q000502:physiology*
D000941:Antigens